Markets:

Overview

News

Currencies

International

Treasuries

(OP:MDXXF)

0.1000 -0.0152 (-13.19%)

Streaming Delayed Price Updated: 2:04 PM EDT, Jul 22, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about MDXXF

PharmAla Biotech To Supply LaNeo MDMA For Mt. Sinai Clinical Trial ↗

October 21, 2024

PharmAla Biotech will supply GMP LaNeo MDMA to Mt. Sinai Health System for clinical research, advancing therapy for neurological disorders.

Via Benzinga

PharmAla Biotech To Supply University Of Texas, San Antonio For Clinical Trial ↗

October 08, 2024

PharmAla Biotech will supply the University of Texas, San Antonio with a novel LaNeo MDMA dosage form for a clinical trial, advancing MDMA research and innovation.

Via Benzinga

PharmAla Biotech To Supply MDMA For Harvard's Maclean Hospital Clinical Trial ↗

October 02, 2024

PharmAla Biotech to supply MDMA for a clinical trial at Harvard's Maclean Hospital. Company also explores European distribution at CPHI Milan Conference.

Via Benzinga

PharmAla Biotech Partners With Johns Hopkins University For MDMA Clinical Trials, Terminates Red Light Holland Contract ↗

September 11, 2024

PharmAla Biotech partners with Johns Hopkins to supply MDMA for clinical trials, terminates contract with Red Light Holland, and presents new APA-01 research at the EBPS Workshop.

Via Benzinga

Canadian Biotech Duo Hits Psilocybin Extraction Milestone For API Development At Scale ↗

May 29, 2024

Red Light Holland and PharmAla achieve psilocybin extraction milestone, advancing API development for scalable medical products. Read now!

Via Benzinga

Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More ↗

April 17, 2024

Via Benzinga

Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More ↗

March 30, 2024

Via Benzinga

Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence ↗

March 29, 2024

Via Benzinga

PharmAla's Novel MDMA Mixture Awarded US Patent, Enabling IP Protection And Further Development ↗

March 27, 2024

Via Benzinga

Topics Intellectual Property

Two Top Biotechs Forge MDMA Supply Deals For Clinical Research ↗

March 26, 2024

Via Benzinga

Truffles To Market: Red Light Holland Wants To Develop Psilocybin API At Scale ↗

March 11, 2024

Via Benzinga

Psychedelics Headlines: Trauma-Informed Care, Valentine's Day & MDMA, Academics On Drugs And More ↗

February 15, 2024

Via Benzinga

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.